Literature DB >> 20478529

Specific killing of Rb mutant cancer cells by inactivating TSC2.

Binghui Li1, Gabriel M Gordon, Charles H Du, Jinhua Xu, Wei Du.   

Abstract

The retinoblastoma (Rb) tumor suppressor is often inactivated in cancers. To identify genes that can be used to specifically target such cancers, we carried out a genetic screen in Drosophila. We identified gig (fly TSC2) and found that inactivation of rbf (fly Rb) and gig synergistically induced cell death. Interestingly, inactivation of TSC2 specifically kills Rb mutant cancer cells under stress conditions, which is correlated with an inhibition of tumor growth. We show that cancer cell killing induced by concomitant inactivation of Rb and TSC2 is mediated by increased cellular stress, including oxidative stress. Inactivation of TSC2 and Rb synergistically induce oxidative stress via increased protein synthesis, inhibited de novo lipid synthesis, and decreased reactive oxygen species scavenger enzyme SOD2 induction. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478529      PMCID: PMC2873973          DOI: 10.1016/j.ccr.2010.03.019

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  44 in total

Review 1.  E2F target genes: unraveling the biology.

Authors:  Adrian P Bracken; Marco Ciro; Andrea Cocito; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2004-08       Impact factor: 13.807

2.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.

Authors:  Qian Yang; Ken Inoki; Eunjung Kim; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

Review 3.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

Review 4.  Quality control against misfolded proteins in the cytosol: a network for cell survival.

Authors:  Hiroshi Kubota
Journal:  J Biochem       Date:  2009-09-07       Impact factor: 3.387

Review 5.  Statins and cancer prevention.

Authors:  Marie-France Demierre; Peter D R Higgins; Stephen B Gruber; Ernest Hawk; Scott M Lippman
Journal:  Nat Rev Cancer       Date:  2005-12       Impact factor: 60.716

Review 6.  Retinoblastoma family genes.

Authors:  W Du; J Pogoriler
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

7.  Drosophila E2F1 has context-specific pro- and antiapoptotic properties during development.

Authors:  Nam-Sung Moon; Maxim V Frolov; Eun-Jeong Kwon; Luisa Di Stefano; Dessislava K Dimova; Erick J Morris; Barbie Taylor-Harding; Kristin White; Nicholas J Dyson
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

8.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

9.  The role of RBF in the introduction of G1 regulation during Drosophila embryogenesis.

Authors:  W Du; N Dyson
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

10.  The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.

Authors:  N J Pearce; J W Yates; T A Berkhout; B Jackson; D Tew; H Boyd; P Camilleri; P Sweeney; A D Gribble; A Shaw; P H Groot
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

View more
  45 in total

1.  Targeting Rb inactivation in cancers by synthetic lethality.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Am J Cancer Res       Date:  2011-06-30       Impact factor: 6.166

2.  Ginseng metabolite protopanaxadiol interferes with lipid metabolism and induces endoplasmic reticulum stress and p53 activation to promote cancer cell death.

Authors:  Hong Ri Jin; Charles H Du; Chong-Zhi Wang; Chun-Su Yuan; Wei Du
Journal:  Phytother Res       Date:  2018-12-09       Impact factor: 5.878

3.  ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling.

Authors:  Zhentao Sheng; Lijia Yu; Tianyi Zhang; Xun Pei; Xuan Li; Zhihua Zhang; Wei Du
Journal:  J Cell Sci       Date:  2016-04-07       Impact factor: 5.285

Review 4.  Redox signaling at invasive microdomains in cancer cells.

Authors:  Begoña Díaz; Sara A Courtneidge
Journal:  Free Radic Biol Med       Date:  2011-09-29       Impact factor: 7.376

5.  Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death.

Authors:  Arpad M Danos; Yang Liao; Xuan Li; Wei Du
Journal:  Cancer Lett       Date:  2012-09-27       Impact factor: 8.679

Review 6.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

7.  Targeting Rb mutant cancers by inactivating TSC2.

Authors:  Jennifer S Searle; Binghui Li; Wei Du
Journal:  Oncotarget       Date:  2010-07

8.  G1 arrest and differentiation can occur independently of Rb family function.

Authors:  Stacey E Wirt; Adam S Adler; Véronique Gebala; James M Weimann; Bethany E Schaffer; Louis A Saddic; Patrick Viatour; Hannes Vogel; Howard Y Chang; Alex Meissner; Julien Sage
Journal:  J Cell Biol       Date:  2010-11-08       Impact factor: 10.539

9.  Deregulated G1-S control and energy stress contribute to the synthetic-lethal interactions between inactivation of RB and TSC1 or TSC2.

Authors:  Gabriel M Gordon; Tianyi Zhang; Jiong Zhao; Wei Du
Journal:  J Cell Sci       Date:  2013-02-27       Impact factor: 5.285

10.  Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.

Authors:  Andrey A Parkhitko; Carmen Priolo; Jonathan L Coloff; Jihye Yun; Julia J Wu; Kenji Mizumura; Wenping Xu; Izabela A Malinowska; Jane Yu; David J Kwiatkowski; Jason W Locasale; John M Asara; Augustine M K Choi; Toren Finkel; Elizabeth P Henske
Journal:  Mol Cancer Res       Date:  2013-12-02       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.